IDL-cholesterol and lipidic parameters in diabetic patients type 2;Colesterol-IDL y parámetros lipídicos en diabéticos tipo 2

Revista Argentina de Endocrinologia y Metabolismo

Volumn 44, Issue 4, 2007, Pages 215-222

  Bonneau, G A ^a,b,c,d   Castillo Rascon M S ^a,b,c   Sanchez R A ^b,c   Pedrozo, W R ^a,b,c   Castro Olivera, C ^a  

^a Hospital Dr Ramon Madariaga   (Argentina)

^b Hospital Pediátrico Dr Fernando Barreyro   (Argentina)

^c UNIVERSIDAD NACIONAL DE MISIONES   (Argentina)

^d NONE   (Argentina)

Author keywords

Atherogenic risk; Diabetes type 2; IDL Cholesterol; Lipoproteins

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE;

EID: 38349056783     PISSN: 03264610     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care vol27 ( sup 1): S5-S10, jan.2004
2. Dirección de Estadísticas- Ministerio de Salud Pública de la provincia de Misiones Defunciones según grupo de edad, sexo y causa de muerte. 2005.
3. Wild, S.; Roglic, G.; Gren, A. y col. Global prevalence of diabetes. Esquemates for the year 2000 and projections for 2030. Diabetes care vol 27 No5: 1047-1053, 2004.
4. Gerich, J.E. Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus. Mayo Clin Proc. 78:447-456; 2003
5. Haffner, S.; Lehto, S.; Ronnemaa, T. y col. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N. Engl. J. Med. 339: 229-234, 1998
6. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 106:3143-3421, 2002.
7. Todd Hurst, R. and Lee, R. Increased Incidence of coronary atheroclerosis in type 2 diabetes mellitus: mechanisms and management. Ann. Intern. Med. 139: 824-834, 2003.
8. Georg, P. and Ludvik, B. Lipids and Diabetes. Reviews. J. Clin. Basic. Cardiol. 3: 159-162, 2000.
9. Krauss, R. M. Lipids and lipoproteins in Patients with type 2 Diabetes. Diabetes Care 27:1496-1504, 2004.
10. Garvey, T.; Kwon S.; Zheng, D. y col. Effects of Insulin Resistance and type 2 Diabetes on Lipoprotein subclass Particle Size and Concentration Determined by Nuclear Magnetic Resonance. Diabetes vol.52: 453-462, feb 2003.
11. Wikinski, R.; Morocoima, E.; Camejo, M. y col. Pre and post prandial plasma levels of intermediate density lipoproteins in type 2 diabetic female patients. Medicina vol 46: 51-58, 1986.
12. Krauss, R. M. Triglycerides and atherogenic lipoproteins: rationale for lipid management. Am J Med 105 (Suppl. 1A): 58S-62S, 1998
13. Wikinski, R. Las lipoproteínas de densidad intermedia en la diabetes mellitus humana y experimental. Tésis doctoral .1983
14. Sirtori, C.; Hassanein, K. M.; Hassanein, R. y col. Phenotyping of type II and IV hiperlipoproteinemia by a simple quantitative agarose gel lipoprotein electrophoresis. Clin. Chim. Acta 31: 305-310, 1971.
15. Beaumont, J.; Carlson L; Cooper, G. y col. Classification of hyperlipidemias and hyperlipoproteinemias, Bull WHO vol 43: 891-970, 1970.
16. Wikinski, R.; Schreier, L y Rosental, S. New method for isolating and quantifying intermediate and beta very low density lipoprotein cholesterol. Clin. Chem. Vol 37 No 11: 1913-1916, 1991.
17. Vergés, B. New insight into the pathophysiology of lipid abnormalities in type 2 diabetes. Diabetes Metab 31:429-439, 2005.
18. Boizel, R.; Benhamou, P.; Lardy, B. y col. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particles size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes care Vol 23 No 11: 1679-1685, 2000.
19. Dobiasova, M. and Frolich, J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterfication rate in apo B-lipoprotein-depleted plasma (FER HDL). Clinical Biochemistry 34:583-588, 2001.
20. Actis Dato, S. y Rebolledo, O. Utilidad de la relación triglicéridos/ col HDL en la Diabetes mellitus. Rev. Soc. Arg. de Diabetes vol 37 No 1: 7-17, 2003.
21. Liu, J.; Sempos, C.; Donahue, R. P. y col. Joint Distribution of Non-HDL and LDL Cholesterol and Coronary Heart Disease Risk Prediction Among Individuals With and Without Diabetes Care 28:1916-1921, 2005.
22. Schulze M. B.; Shail, I. and Manson, J. E. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women With type 2 diabetes Diabetologia 47:2129-2136, 2004.
23. Wagner, A. M.; Perez, A. y Zapico, E. Non-HDL Cholesterol and Apolipoprotein B in the Dyslipidemic Classification of Type 2 Diabetic Patients. Diabetes Care 26:2048-2051, 2003
24. Lu, W.; Resnick, H.; Jablonski, K. y col. Non-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes. The Strong Heart Study. Diabetes Care vol26 No 1: 16-22, Jan 2003
25. Schreier, L; Berg, G; Rosental, S. y col. Colesterol-IDL y/o col-,-VLDL: un nuevo parámetro en diferentes fenotipos lipoproteicos. Acta Bioq. Clin. Latinoamericana vol XXVII No1:65-74. 1993
26. Segrest. The Role of non-LDL: non-HDL Particles in Atherosclerosis . Curr. Diab. Rep. 2(3): 282-288 (review) 2002
27. Krauss, R. M. Atherogenicity of triglyceride-rich lipoproteins. Am J Cardiol. 81:13B-17B, 1998
28. Hodis, H. N.; Mack, W. J.; Dunn, M. y col. Intermediate-Density Lipoproteins And Progression Of Carotid Arterial Wall Intima-Media Thickness. Circulation 95:2022-2026, 1997.